Featuring news, events and industry trends
Burke Neurological Institute Receives a $45 Million NIH Grant to Study a Vitamin B1 Precursor for Treatment of Alzheimer’s Disease in Multi-center Clinical Trial

This follow-up trial will expand on previous work completed at BNI, suggesting that high levels of benfotiamine significantly slowed the rate of functional decline in participants with mild cognitive impairment or early Alzheimer’s disease.

There is enormous unmet need regarding both treatment and prevention of Alzheimer’s disease in the growing and aging population. More than six million Americans are living with Alzheimer’s disease, which is forecasted to rise to nearly 13 million by 2050. Globally, the prevalence of Alzheimer’s disease is projected to rise from 57 million to 153 million in 2050. There is no true cure for the disease and no effective treatments exist. Clinical trials over the last decade have frequently failed, and the most recently approved therapy has been met with controversy regarding efficacy, safety, value and pricing. Treatments for Alzheimer’s disease and mild cognitive impairment that are effective, safe, and affordable are critically needed across the globe.
Retia Medical Raises $15 Million to Accelerate Commercialization of the Argos Hemodynamic Monitor

Retia Medical in Valhalla, an innovator in advanced hemodynamic monitoring, recently announced that it has secured $15 million in Series B funding. The financing round was led by Fresenius Medical Care Ventures with participation from a second strategic investor, Red Cedar Ventures, and existing investor, the Pritzker-Vlock Family Office. Retia Medical will use the funding to expand its commercial team and accelerate the development of its next-generation algorithms for guiding care for high-risk patients.
Westchester County Biosciences Accelerator Alum Insu Health Design Featured in Telemundo

Insu Health Design is an innovation and social-driven corporation focused on reducing health disparities through novel technology and design, beginning with personal storage for temperature-sensitive medications. Telemundo recently featured the product designed to keep medication safe and protected at all time.
New Data Shows Teladoc Health’s Integrated Chronic Care Solutions Deliver Improved Health Outcomes

Purchase headquartered Teladoc Health , the global leader in whole-person virtual care, released new findings showing that managing multiple chronic conditions with a single, integrated approach leads to better control of A1c, systolic blood pressure and weight better than any diabetes, hypertension or weight control program alone. These clinically significant health outcomes were accompanied by better consumer engagement as Livongo by Teladoc Health members reported higher satisfaction and net promoter scores (NPS). These results position Teladoc Health to move further into value-based care with “full fees at risk” outcomes-based performance guarantees. 

According to the CDC, more than 40% of adults in the U.S. have two or more chronic conditions, making Teladoc Health’s findings relevant for millions of Americans.                                 
 WCBA 2023 Strengthening Your Application

Date: July 20
Time: 12:00 PM

NYC Builds Bio Presents Gateways to the North: From the Bronx to Westchester
Date: July 26
Time: 12:00 PM

MedTech’s Empire State Focus ’22 Series: Westchester/Hudson Valley
Date: July 28
Time: 10:00 AM

WCBA 2023 Information Session Hosted with Einstein Office of Biotechnology and Business Development

Date: August 2
Time: 12:00 PM

NewYorkBIO’s Virtual Manufacturing Summit
Date: August 5
Time: 9:00 AM

WCBA 2023 Strengthening Your Application 

Date: August 10
Time: 10:00 AM

WCBA 2023 Strengthening Your Application 

Date: August 18
Time: 5:00 PM

WCBA 2023 Strengthening Your Application 

Date: August 26
Time: 12:00 PM

Have good news to share from
Westchester’s bioscience ecosystem?

Please let us know.

If you would like to continue receiving this weekly newsletter,
please sign up below. If you would like to contact us directly, click the Contact Us link.